Zobrazeno 1 - 6
of 6
pro vyhledávání: '"IL12, interleukin 12"'
Autor:
Wenchao Wei, Chi Chun Wong, Xiang Zhang, Jun Yu, Weixin Liu, Feixue Wang, Yunfei Zhou, Dabin Liu, Joseph J.Y. Sung
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 1, Pp 257-274 (2022)
Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology
Background & Aims Hepatic immune microenvironment plays a pivotal role in the development of nonalcoholic steatohepatitis (NASH). However, the role of natural killer (NK) cells, accounting for 10%–20% of liver lymphocytes, in NASH is still unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c28da1742a020c4b72f0c4a997351c0
http://www.sciencedirect.com/science/article/pii/S2352345X21001867
http://www.sciencedirect.com/science/article/pii/S2352345X21001867
Autor:
Majid Yaran, Daniel Kotlarz, Vajihe Ostadi, Christoph Klein, Mahdieh Behnam, Razieh Khoshnevisan, Roya Sherkat, Nioosha Nekooei-marnany, Abbas Rezaei
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 17, Iss, Pp-(2019)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Background: The interleukin-12 receptor β1 (IL-12Rβ1) deficiency is a primary immunodeficiency (PID), affecting the immunological pathway of interleukin 12/interferon- γ (IL12/IFN-γ) axis and interleukin 23 receptor (IL23R). Defect in this pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36434be8cc98fe856d2967f094589172
http://www.sciencedirect.com/science/article/pii/S2405579419300646
http://www.sciencedirect.com/science/article/pii/S2405579419300646
Autor:
Casper Rokx, Tsung Wai Kan, Tokameh Mahmoudi, Mateusz Stoszko, Elisa De Crignis, Cynthia Lungu, Robert-Jan Palstra, Annelies Verbon, Emily C. Dykhuizen, Charles A. Boucher, Mir M. Khalid
Publikováno v:
EBioMedicine, Vol 3, Iss C, Pp 108-121 (2016)
EBioMedicine
EBioMedicine, 3, 108-121. Elsevier
EBioMedicine
EBioMedicine, 3, 108-121. Elsevier
Persistence of latently infected cells in presence of Anti-Retroviral Therapy presents the main obstacle to HIV-1 eradication. Much effort is thus placed on identification of compounds capable of HIV-1 latency reversal in order to render infected cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e28d0cb1f395267e05515a5705b4c3
https://doi.org/10.1016/j.ebiom.2015.11.047
https://doi.org/10.1016/j.ebiom.2015.11.047
Autor:
Khoshnevisan R; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran., Nekooei-Marnany N; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Klein C; Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany., Kotlarz D; Dr. von Hauner Children's Hospital, Department of Pediatrics, University Hospital, LMU Munich, Munich, Germany., Behnam M; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran., Ostadi V; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran.; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Yaran M; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Rezaei A; Immunology Department, Isfahan University of Medical Sciences, Isfahan, Iran.; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Sherkat R; Aquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Publikováno v:
Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2019 Sep 20; Vol. 17, pp. 100123. Date of Electronic Publication: 2019 Sep 20 (Print Publication: 2019).
Autor:
Stoszko M; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., De Crignis E; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., Rokx C; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, The Netherlands., Khalid MM; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., Lungu C; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., Palstra RJ; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., Kan TW; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands., Boucher C; Department of Viroscience, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, the Netherlands., Verbon A; Department of Internal Medicine, Section of Infectious Diseases, Erasmus University Medical Center, PO Box 2040 3000CA, Rotterdam, The Netherlands., Dykhuizen EC; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA., Mahmoudi T; Department of Biochemistry, Erasmus University Medical Center, Ee634, PO Box 2040 3000CA, Rotterdam, The Netherlands. Electronic address: t.mahmoudi@erasmusmc.nl.
Publikováno v:
EBioMedicine [EBioMedicine] 2015 Nov 27; Vol. 3, pp. 108-121. Date of Electronic Publication: 2015 Nov 27 (Print Publication: 2016).
Autor:
Singh S; a Department of Biotherapeutics Research; Boehringer Ingelheim Pharmaceuticals Inc. ; Ridgefield , CT , USA., Kroe-Barrett RR, Canada KA, Zhu X, Sepulveda E, Wu H, He Y, Raymond EL, Ahlberg J, Frego LE, Amodeo LM, Catron KM, Presky DH, Hanke JH
Publikováno v:
MAbs [MAbs] 2015; Vol. 7 (4), pp. 778-91. Date of Electronic Publication: 2015 Apr 23.